The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Oramox 250 mg/5 ml Powder for Oral Suspension



Athlone Laboratories LtdPA0298/019/002

Main Information

Trade NameOramox 250 mg/5 ml Powder for Oral Suspension
Active SubstancesAmoxicillin
Dosage FormPowder for oral suspension
Licence HolderAthlone Laboratories Ltd
Licence NumberPA0298/019/002

Group Information

ATC CodeJ01CA Penicillins with extended spectrum
J01CA04 amoxicillin

Status

License statusAuthorised
Licence Issued27/09/1988
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to market only product authorised in Ireland under the PA0298/010/002.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back